Mei-Jie Zhang mostly deals with Transplantation, Internal medicine, Surgery, Leukemia and Bone marrow. His Transplantation study incorporates themes from Regimen, Proportional hazards model and Chemotherapy. The Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
His studies deal with areas such as Histocompatibility and Cohort as well as Surgery. His research investigates the connection with Leukemia and areas like Myeloid which intersect with concerns in Chronic lymphocytic leukemia. His Bone marrow research includes elements of Hematology, Umbilical Cord Blood Transplantation, Human leukocyte antigen, Chronic myelogenous leukemia and Cord Blood Stem Cell Transplantation.
Mei-Jie Zhang spends much of his time researching Internal medicine, Transplantation, Surgery, Oncology and Hematopoietic stem cell transplantation. His Internal medicine study frequently links to related topics such as Gastroenterology. In his research, Histocompatibility and Human leukocyte antigen is intimately related to Bone marrow, which falls under the overarching field of Transplantation.
His work on Surgery is being expanded to include thematically relevant topics such as Multiple myeloma. His work carried out in the field of Oncology brings together such families of science as Autologous transplantation, Hematopoietic cell, Myeloid leukemia and Allogeneic transplantation. His research integrates issues of Young adult, Regimen, Retrospective cohort study, Cumulative incidence and Lymphoma in his study of Hematopoietic stem cell transplantation.
Mei-Jie Zhang mainly focuses on Internal medicine, Transplantation, Oncology, Hazard ratio and Hematopoietic stem cell transplantation. Transplantation is the subject of his research, which falls under Surgery. His biological study spans a wide range of topics, including Cancer, Multiple myeloma, Bortezomib, Allogeneic transplantation and Complete remission.
His Hazard ratio study integrates concerns from other disciplines, such as Clinical trial, Adverse effect, Cumulative incidence, Retrospective cohort study and Proportional hazards model. His work carried out in the field of Hematopoietic stem cell transplantation brings together such families of science as Chemotherapy regimen, Survival rate, Lymphoma, Bone marrow and Acute lymphocytic leukemia. His Leukemia study combines topics from a wide range of disciplines, such as Myeloid and Umbilical Cord Blood Transplantation, Human leukocyte antigen.
His primary areas of study are Transplantation, Internal medicine, Hazard ratio, Survival analysis and Hematopoietic stem cell transplantation. Transplantation is a subfield of Surgery that Mei-Jie Zhang investigates. His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
Mei-Jie Zhang works mostly in the field of Hazard ratio, limiting it down to topics relating to Proportional hazards model and, in certain cases, ABO blood group system and Young adult, as a part of the same area of interest. His studies deal with areas such as Sample size determination, Outcome and Covariate, Instrumental variable, Econometrics as well as Survival analysis. Mei-Jie Zhang focuses mostly in the field of Hematopoietic stem cell transplantation, narrowing it down to topics relating to Fludarabine and, in certain cases, Melphalan, Clofarabine, Total body irradiation, Busulfan and Progression-free survival.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Vanderson Rocha;John E. Wagner;Kathleen A. Sobocinski;John P. Klein.
The New England Journal of Medicine (2000)
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
Mary Eapen;Pablo Rubinstein;Mei Jie Zhang;Cladd Stevens.
The Lancet (2007)
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation
Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis.
IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
Rowlings Pa;Przepiorka D;Klein Jp;Gale Rp.
British Journal of Haematology (1997)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.
Dao-Pei Lu;Dao-Pei Lu;Lujia Dong;Lujia Dong;Tong Wu;Tong Wu;Xiao-Jun Huang;Xiao-Jun Huang.
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis
Mary Eapen;Vanderson Rocha;Guillermo Sanz;Andromachi Scaradavou.
Lancet Oncology (2010)
Results of Allogeneic Bone Marrow Transplants for Leukemia Using Donors Other Than HLA-Identical Siblings
R Szydlo;J M Goldman;J P Klein;R P Gale.
Journal of Clinical Oncology (1997)
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao.
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey.
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling
Jon J. Van Rood;Fausto R. Loberiza;Mei Jie Zhang;Machteld Oudshoorn.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: